Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$448M |
| 2 |
Wells Fargo
WFC
|
+$443M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$401M |
| 4 |
Delta Air Lines
DAL
|
+$368M |
| 5 |
DuPont de Nemours
DD
|
+$336M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE Value ETF
EFV
|
+$879M |
| 2 |
Target
TGT
|
+$339M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$323M |
| 4 |
Monster Beverage
MNST
|
+$279M |
| 5 |
Goldman Sachs
GS
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.16% |
| 2 | Financials | 13.52% |
| 3 | Healthcare | 11.13% |
| 4 | Consumer Discretionary | 9.37% |
| 5 | Industrials | 8.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
WisdomTree US MidCap Fund
EZM
$949M
| $3.24M | ﹤0.01% |
81,603
+10,264
| +14% | +$407K |
|
2452
Global X MLP & Energy Infrastructure ETF
MLPX
$3.6B
| $3.24M | ﹤0.01% |
80,944
+59,936
| +285% | +$2.29M |
|
2453
MYR Group
MYRG
$5.33B
| $3.23M | ﹤0.01% |
91,168
-10,953
| -11% | -$387K |
|
2454
Donnelley Financial Solutions
DFIN
$1.19B
| $3.23M | ﹤0.01% |
186,050
+9,038
| +5% | +$156K |
|
2455
UNIFI
UFI
$119M
| $3.23M | ﹤0.01% |
101,938
+10,193
| +11% | +$336K |
|
|
IBDL
2456
DELISTED
iShares iBonds Dec 2020 Term Corporate ETF
IBDL
| $3.23M | ﹤0.01% |
129,033
+32,275
| +33% | +$808K |
|
2457
Rexford Industrial Realty
REXR
$8.41B
| $3.22M | ﹤0.01% |
102,651
-1,497
| -1% | -$45.8K |
|
2458
Jefferies Financial Group
JEF
$12.8B
| $3.22M | ﹤0.01% |
158,129
-8,571
| -5% | -$180K |
|
2459
Myers Industries
MYE
$1.37B
| $3.21M | ﹤0.01% |
167,191
+33,275
| +25% | +$710K |
|
2460
Vanguard Russell 2000 ETF
VTWO
$17.6B
| $3.2M | ﹤0.01% |
48,800
+8,508
| +21% | +$547K |
|
2461
Fortune Brands Innovations
FBIN
$6.24B
| $3.2M | ﹤0.01% |
68,986
-1,475
| -2% | -$71.5K |
|
2462
Bank of N.T. Butterfield & Son
NTB
$2.46B
| $3.2M | ﹤0.01% |
69,893
+16,544
| +31% | +$782K |
|
2463
Invesco S&P MidCap 400 Revenue ETF
RWK
$1.33B
| $3.18M | ﹤0.01% |
52,115
-1,453
| -3% | -$87.9K |
|
2464
First Trust Consumer Staples AlphaDEX Fund
FXG
$226M
| $3.17M | ﹤0.01% |
67,285
-21,979
| -25% | -$1.02M |
|
2465
Invesco S&P Emerging Markets Low Volatility ETF
EELV
$428M
| $3.16M | ﹤0.01% |
130,879
+21,274
| +19% | +$547K |
|
2466
Triumph Financial Inc
TFIN
$1.84B
| $3.15M | ﹤0.01% |
77,344
-23,303
| -23% | -$942K |
|
2467
eHealth
EHTH
$44.8M
| $3.14M | ﹤0.01% |
142,162
+56,972
| +67% | +$1.1M |
|
2468
ING
ING
$101B
| $3.14M | ﹤0.01% |
225,244
-413
| -0.2% | -$6.56K |
|
|
FSD
2469
DELISTED
FIRST TRUST HIGH INCOME LONG/SHORT FUND
FSD
| $3.13M | ﹤0.01% |
212,642
+23,135
| +12% | +$345K |
|
2470
Zumiez
ZUMZ
$347M
| $3.13M | ﹤0.01% |
124,960
+13,292
| +12% | +$331K |
|
2471
WisdomTree US AI Enhanced Value Fund
AIVL
$431M
| $3.13M | ﹤0.01% |
35,989
+3,343
| +10% | +$288K |
|
|
ODT
2472
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $3.12M | ﹤0.01% |
141,444
+5,212
| +4% | +$121K |
|
2473
Invesco S&P 500 Value with Momentum ETF
SPVM
$131M
| $3.12M | ﹤0.01% |
82,639
+40,086
| +94% | +$1.53M |
|
2474
Coherus Oncology
CHRS
$224M
| $3.1M | ﹤0.01% |
221,350
-191,105
| -46% | -$2.74M |
|
2475
Bath & Body Works
BBWI
$4.2B
| $3.08M | ﹤0.01% |
103,189
-2,553,327
| -96% | -$73.7M |
|
Similar funds
Ameriprise's Q2 2018 Portfolio in Review
As of Q2 2018, Ameriprise held 3,794 positions worth $226B, up 2.3% from $221B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Ameriprise's Q2 2018 filing shows 174 new, 1,922 increased, 1,417 reduced and 161 closed positions. Its largest new stake was GreenSky, Inc. Class A Common Stock: 3,371,225 shares worth $71.3M. The largest sale was iShares MSCI EAFE Value ETF, an estimated $879M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q2 2018 buy was GreenSky, Inc. Class A Common Stock: 3,371,225 shares worth $71.3M.
- Ameriprise added most to Bristol-Myers Squibb in Q2 2018, an estimated $448M increase.
- Ameriprise's biggest Q2 2018 reduction was iShares MSCI EAFE Value ETF, cutting an estimated $879M.
- Ameriprise fully exited Time Warner Inc in Q2 2018, selling an estimated $231M.
- Ameriprise's ten largest holdings make up 14% of its $226B portfolio in Q2 2018.
- Ameriprise opened 174 new positions and closed 161 in Q2 2018.
- Ameriprise's portfolio value rose 2.3% quarter-over-quarter to $226B.
Based on Ameriprise's 13F filing for Q2 2018, filed 14 Aug 2018.